Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
19.93
-0.63 (-3.06%)
At close: Dec 5, 2025, 4:00 PM EST
20.32
+0.39 (1.96%)
After-hours: Dec 5, 2025, 4:15 PM EST

Forte Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2018
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2018
Net Income
-51.74-35.48-31.48-13.88-21.71-46.49
Upgrade
Depreciation & Amortization
0.060.040.01-0.040.05
Upgrade
Asset Writedown & Restructuring Costs
----0.0630.89
Upgrade
Loss (Gain) From Sale of Investments
-0.4-0.16-0.13---
Upgrade
Stock-Based Compensation
5.293.13.284.014.210.96
Upgrade
Change in Accounts Payable
0.333.020.270.21-0.29-0.37
Upgrade
Change in Other Net Operating Assets
2.04-1.26-0.661.471.01-3.46
Upgrade
Operating Cash Flow
-44.43-30.75-28.71-8.19-16.68-18.42
Upgrade
Capital Expenditures
-0.15-0.04-0.09---
Upgrade
Cash Acquisitions
-----3.58
Upgrade
Investment in Securities
0.39-35.960.14---
Upgrade
Investing Cash Flow
0.25-35.990.05--3.58
Upgrade
Issuance of Common Stock
129.8253.0125.027.240.0666.96
Upgrade
Repurchase of Common Stock
-0.03-0.04-0.06---
Upgrade
Other Financing Activities
-8.56-1.12-0.27--0.11-0.29
Upgrade
Financing Cash Flow
121.2351.8624.687.24-0.0466.67
Upgrade
Net Cash Flow
77.05-14.88-3.98-0.94-16.7251.83
Upgrade
Free Cash Flow
-44.57-30.78-28.79-8.19-16.68-18.42
Upgrade
Free Cash Flow Per Share
-3.78-10.56-22.80-11.77-29.85-62.59
Upgrade
Levered Free Cash Flow
-24.48-16.14-17.4-3.18-9.02-8.1
Upgrade
Unlevered Free Cash Flow
-24.48-16.14-17.4-3.18-9.02-8.1
Upgrade
Change in Working Capital
2.371.76-0.391.680.72-3.83
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.